MedTrace Logo

Preventing Depression Relapse With Mindfulness-Based Cognitive Therapy

NCT00183560 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 184

Last updated 2015-07-01

No results posted yet for this study

Summary

This study will determine the effectiveness of mindfulness-based cognitive therapy (MBCT) in preventing depression relapse.

Conditions

Interventions

BEHAVIORAL

Mindfulness based cognitive therapy (MBCT)

Following antidepressant discontinuation, participants receive MBCT, an 8-week group program that integrates aspects of cognitive therapy and mindfulness meditation.

DRUG

Antidepressants

Participants continue on dosage of the antidepressant that was used to achieve clinical remission.

DRUG

Placebo plus clinical management

Following discontinuation of active antidepressant, participants are placed onto the placebo and clinical management regimen.

Sponsors & Collaborators

  • National Institute of Mental Health (NIMH)

    collaborator NIH

  • Centre for Addiction and Mental Health

    lead OTHER

Principal Investigators

  • Zindel V. Segal, PhD · Center for Addiction and Mental Health

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2004-07-31
Primary Completion
2010-10-31
Completion
2010-10-31

Countries

  • Canada

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00183560 on ClinicalTrials.gov